How do you avoid medical or drug-like claims for lip repair in Middle East lip care?

In the Middle East, avoid direct medical terms like 'repair,' 'cure,' or 'treat' on lip care. Use functional language such as 'soothes' or 'nourishes.' We help structure compliant claims and prepare the necessary supporting documents for market submission.

Middle East buyer view Launch planning Updated: May 8, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • Strict Middle East regulators (like SFDA in Saudi Arabia, MOH in UAE) prohibit drug-like claims for cosmetics.
  • Words like ‘repair,’ ‘heal,’ ‘therapeutic,’ or references to specific conditions (e.g., ‘cheilitis’) will classify your product as a drug, requiring a different registration pathway.
  • For lip care, focus on permitted functional benefits: ‘soothes dryness,’ ‘provides intense moisturization,’ ‘protects from environmental factors,’ or ‘improves the appearance of dry lips.’ We structure your product concept and label copy within these boundaries during the R&D brief.
  • Key details: MOQ is typically 5k-10k units for a compliant lip product line with tailored packaging.
  • Our sampling timeline is 4-6 weeks for formula and primary packaging compatibility checks.
  • Essential testing includes challenge tests for preservative efficacy in humid climates and sun protection factor (SPF) verification if claimed.
  • We provide a Product Information File (PIF), GMP certificate, and arrange for any required third-party testing reports (e.g., heavy metals, microbial limits) for your regulatory agent.
  • The full production lead time, post-sample approval, is 10-12 weeks including stability testing for high-temperature markets.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).